American Biogenetic Sciences, Inc. - Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Net loss	$ (18,780)	$ (25,382)
Expenses paid by issuance of common stock	0	0
Fair value of services provided by related parties	14,000	19,000
Increase (decrease) in accounts payable and accrued expenses	4,780	6,382
Cash flows used by operating activities	0	0
Cash used in investing activities	0	0
Procceds from related party borrowings	0	0
Cash generated by financing activities	0	0
Change in cash	0	0
Cash - beginning of period	0	0
Cash - end of period	$ 0	$ 0